Dätwyler Holding AG (SWX:DAE)
| Market Cap | 2.67B |
| Revenue (ttm) | 1.10B |
| Net Income (ttm) | 80.80M |
| Shares Out | 17.00M |
| EPS (ttm) | 4.75 |
| PE Ratio | 33.07 |
| Forward PE | 25.94 |
| Dividend | 3.20 (2.04%) |
| Ex-Dividend Date | Mar 19, 2026 |
| Volume | 7,634 |
| Average Volume | 10,177 |
| Open | 154.40 |
| Previous Close | 157.20 |
| Day's Range | 154.40 - 159.20 |
| 52-Week Range | 112.20 - 171.60 |
| Beta | 1.09 |
| RSI | 61.23 |
| Earnings Date | Jul 23, 2026 |
About Dätwyler Holding AG
Dätwyler Holding AG engages in the production and sale of elastomer components for healthcare, automotive, industries, and food and beverage industries in Switzerland, rest of Europe, North and South America, Asia, and internationally. It operates in two divisions, Healthcare and Industrial. The Healthcare division offers rubber components for prefilled syringes, pens, and injection systems; components and closures for injectable drugs in vials; and rubber components for blood collection systems, IV administration sets, disposable syringes, dia... [Read more]
Financial Performance
In 2025, Dätwyler Holding AG's revenue was 1.10 billion, a decrease of -0.65% compared to the previous year's 1.11 billion. Earnings were 80.80 million, an increase of 159.81%.
Financial StatementsNews
Full Year 2025 Daetwyler Holding AG Earnings Call Transcript
Full Year 2025 Daetwyler Holding AG Earnings Call Transcript
Dätwyler Holding AG Earnings Call Transcript: H2 2025
Net revenue reached CHF 1.1 billion in 2025, with Healthcare driving margin expansion and operational improvements. The transformation program and Capsul'in acquisition supported strategic growth, while net debt and leverage improved. 2026 outlook focuses on execution and structural trends.
Dätwyler Holding AG Transcript: CMD 2025
Management is executing a transformation program to drive growth in high-value, system-critical components, focusing on healthcare and industrial niches with strong innovation and operational leverage. Midterm targets include higher single-digit revenue growth and a 17%+ EBIT margin, supported by portfolio optimization and disciplined capital allocation.
Dätwyler Holding AG Earnings Call Transcript: H1 2025
Solid H1 2025 performance with EBIT margin up to 12.2% and strong Healthcare growth, despite FX headwinds and weak automotive demand. Transformation program and high value product focus drive improved profitability and outlook.
Daetwyler Holding AG (XSWX:DAE) Full Year 2024 Earnings Call Highlights: Navigating Challenges ...
Daetwyler Holding AG (XSWX:DAE) Full Year 2024 Earnings Call Highlights: Navigating Challenges with Strategic Wins
Dätwyler Holding AG Earnings Call Transcript: H2 2024
Revenue declined 3.8% year-over-year to CHF 1,108 million, but operational margins remained stable due to cost management. The Forward Now transformation program incurred CHF 37.9 million in one-time costs, aiming for significant profit improvements by 2027.
Dätwyler Holding AG Earnings Call Transcript: H1 2024
Revenue declined 5% year-over-year, but EBIT rose 11.6% and margin improved to 11.8% due to cost efficiencies. Healthcare remains weak from destocking, while Industrial Solutions saw profit growth. Full-year EBIT margin is expected above last year, with long-term growth tied to market normalization.